Archive · 28 Jul 2025
Pharma Sector News: Land, Recalls, Approvals, and Court Ruling
Several pharmaceutical companies announced developments.
Laurus Labs plans a new pharma zone in Andhra Pradesh.
Sun Pharma, Lupin, and Dr. Reddy's are recalling drugs in the US.
Genpharmasec acquired Derren Healthcare.
Alembic got USFDA approval for a new drug, and the Delhi High Court ruled in a patent dispute between Zydus and Roche.
Laurus Labs secured land in Andhra Pradesh to establish a pharma zone.
Sun Pharma, Lupin, and Dr. Reddy's Laboratories are recalling drugs in the US.
Genpharmasec acquired a 70% stake in Derren Healthcare.
Alembic Pharmaceuticals received USFDA approval for Carbamazepine Extended-Release Tablets.
Delhi High Court declined to compel Zydus Lifesciences to disclose its drug manufacturing process.
- Who
- Laurus Labs, Sun Pharma, Lupin, Dr. Reddy's Laboratories, Genpharmasec, Derren Healthcare, Alembic Pharmaceuticals, Zydus Lifesciences, F. Hoffmann-La Roche.
- What
- Various pharmaceutical company announcements including land allocation, recalls, acquisitions, approvals, and a court ruling.
- When
- Announcements made on or before July 28, 2025.
- Where
- India and the United States.
- Why
- Company expansion, regulatory actions, market approvals, and legal disputes.
F. Hoffmann-La Roche
Zydus Lifesciences
Patent Dispute
F. Hoffmann-La Roche
Argues for the disclosure of Zydus Lifesciences' manufacturing process for patent infringement.
Zydus Lifesciences
Zydus Lifesciences' position regarding confidentiality of their manufacturing process.
- Companies Involved
- Laurus Labs, Sun Pharma, Lupin, Dr. Reddy's, Genpharmasec, Derren Healthcare, Alembic Pharma, Zydus, Roche
- Land Allotment (Laurus Labs)
- 531.77 acres
- Laurus Labs Investment
- ₹5,630 crore
- Genpharmasec Acquisition
- 70% stake in Derren Healthcare
- Genpharmasec Purchase Consideration
- ₹34.15 crore
- Alembic Approval
- Carbamazepine Extended-Release Tablets
- USFDA Approval
- Alembic Pharmaceuticals
- Delhi High Court Decision
- Zydus Lifesciences manufacturing process undisclosed
